Corinne de Vries heads the Office for Science and Innovation Support in the Human Medicines Research & Development Support Division at the European Medicines Agency. In this office, Corinne coordinates the involvement of EMA with externally funded regulatory science projects such as those funded under Horizon 2020 and Horizon Europe. In this role, she is on the Scientific Committee of the Innovative Medicines Initiative (a public-private partnership funding scheme of Horizon 2020). EMA is keen to bridge the gap between academia and regulators to help enhance successful development of innovative medicines and have developed a number of initiatives to help achieve this.
Before making the move to the regulatory environment, Corinne worked in academia for 20 years where she led on
pharmacoepidemiology research, including drug safety in pregnancy studies.
GapSummit is the premier, global, intergenerational biotechnology summit that attracts world leaders and the next generation of leaders to substantively discuss pressing challenges facing the bioeconomy and catalyze innovation to address these challenges.
GBR is a not-for-profit that connects biotech think-tanks, industrial leaders and research pioneers to young bio-leaders of tomorrow. GBR is solely led by young passionate and engaged researchers, students and professionals from across the world. GapSummit is GBR’s flagship event to advance its mission of developing and inspiring the next generation of leaders in the global bio-economy.